Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, and T-cell and B-cell Immunology.
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases
Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer
MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer
Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death
LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases
Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis
E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination
Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation
E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation
T Cell Activation Threshold Regulated by E3 Ubiquitin Ligase Cbl-b Determines Fate of Inducible Regulatory T Cells
E3 Ubiquitin Ligase Cbl-b Regulates Pten via Nedd4 in T Cells Independently of Its Ubiquitin Ligase Activity